Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Influence of Epigenetic Mechanisms on the Development of Metabolic Dysfunction Associated Steatotic Liver Disease: A Review.

Journal of gastrointestinal and liver diseases : JGLD - 27 Mar 2026

Zhelezniakova Natalia, Aleksandrova Tetiana

Abstract excerpt

Metabolic dysfunction-associated steatotic liver disease (MASLD) occupies a leading place in the structure of modern hepatology. A growing body of literature identifies MASLD as a global epidemic. Accumulated data from studies in the field of hepatology support the idea that MASLD is a hepatic manifestation of a systemic metabolic disease. MASLD is a multifactorial metabolic disease associated with the presence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Methylation
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Liver

Share to Genetic Predisposition to Disease

Source

Identifiers

PMID: 41894713
DOI: 10.15403/jgld-6581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Influence of Epigenetic Mechanisms on the Development of Metabolic Dysfunction Associated Steatotic Liver Disease: A Review.PMID 41894713Read ↗

Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read ↗

Role of genetic variants and DNA methylation of lipid metabolism-related genes in metabolic dysfunction-associated steatotic liver diseaseSemantic proximity Read ↗

Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatmentSemantic proximity Read ↗

An Update in Epigenetics in Metabolic-Associated Fatty Liver DiseaseSemantic proximity Read ↗

Update on genetics and epigenetics in metabolic associated fatty liver diseaseSemantic proximity Read ↗

Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liverSemantic proximity Read ↗

Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Epigenetic Mechanisms and Their Role in Non-Alcoholic Fatty Liver Disease (NAFLD) PathogenesisSemantic proximity Read ↗

Insights into the role of nucleotide methylation in metabolic-associated fatty liver diseaseSemantic proximity Read ↗

Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging fieldSemantic proximity Read ↗

Genetics and epigenetics purpose in nonalcoholic fatty liver disease.Semantic proximity Read ↗

The contribution of genetics and epigenetics to MAFLD susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.